Voter Votes Health care
  home about us join us contact us site map
business Health care issues
education
energy
environment
finance
foreign policy
health care
human rights
law & order
military
science & technology
taxes
everything else

"Those who expect to reap the blessings of freedom must, like mean, undergo the fatigue of supporting it." — Thomas Paine


What they say
(They, the politicians and pundits)

BUSH:   "Under the law (we) passed, seniors can choose to receive a drug discount card, saving them 10 to 25% of the retail price of most prescription drugs - and millions of low-income seniors can get an additional $600 to buy medicine."
KERRY:   "You don't value families by denying real prescription drug coverage to seniors, so big drug companies can get another windfall...And together, we will make sure that senior citizens never have to cut their pills in half because they can't afford life-saving medicine."
"This legislation should be referred to as the 'Get Your Drugs from Who Knows Where Act' because no one - not the FDA, not the pharmacists, not the doctors, not Senator Dorgan and certainly not the patients - will know where the imported drugs REALLY came from."
Dr. Merrill Matthews, Institute for Policy Innovation, a Texas think tank founded by former Congressman Dick Armey (R-TX)
"We should really fear S2328's side effects.   The bill's provisions would result in the crippling of prescription drug research and development in the United States."
Charles G. Hardin, President of RetireSafe.org, a group of about 300,000 seniors dedicated to privatization
"We should be focusing on the safe, practical alternatives to risky importation including Medicare- approved discount cards and the hundreds of patient-assistance and discount programs (available through "www.helpingpatients.org" that help millions of patients every year, and the provision of more and better drug coverage."
Pharmaceutical Research and Manufacturers of America
"The United States represents the largest pharmaceutical market in the world.   Our taxpayers make substantial investment in pharmaceutical research and development.   And yet Americans are still paying 30-75% more for their prescriptions than consumers in Canada, the European Union and elsewhere."
Sen. John McCain (R-AZ)
 
Canadian flag
 
"I cannot explain to my mother any longer why she should pay twice or two-thirds more than what is paid in Canada or Mexico."
Sen. Trent Lott (R-MS)
"It's time to stop asking the outdated question of whether we should allow it and start enacting solutions that will give consumers the price relief and safety assurances they need."
Sen. Herb Kohl (D-WI)
"It's not about putting folks on a bus to go to Canada.   It's about the local pharmacy being able to do business with pharmacies in Canada."
Sen. Debbie Stabenow (D-MI)
"I'm concerned about quality.   I'm concerned about Canadian law.   I don't want to import a Canadian law.   Canada is concerned with the safety of Canadians, not Americans."
Sen. Don Nickles (R-OK)
"People have come in to me showing me bottles with a big grin on their face saying, 'Hey, look!   I got this from Canada and it was cheaper!'   Then you look at the bottle and the country of origin isn't specified."
Richard Blum M.D., Medical Director of United Cerebral Palsy of Suffolk County, NY
"The safety of drugs purchased from these sources cannot be ensured.   Drugs produced outside the United States may be counterfeit."
Elizabeth G. Durant, Bureau of Customers and Border Protection
"The FDA has consistently concluded that it is unable to endorse a buyer-beware approach."
John Taylor, FDA Associate Commission for Regulatory Affairs
 
 
What we say
(We, the people)

"Let's just allow folks the opportunity to decide for themselves (for a change) what is best for them.   Government needs to get out of the nanny business."
S.
Ocoee, Florida
"I prefer if you want to ruin the quality of (the) drug market, you do under the eyes of the goverment instead of putting more people in harm's way to save people a few dollars."
J.
Maryland
"As scary as it may be, it always comes down to the money.   I need to save everywhere that I can.   Prescriptions are too costly."
Mari
Aurora, Colorado
"I think we can each take some responsibility for knowing where we are buying our drugs.   There are many countries that have strict safety laws, and we can do our own research."
B. L.
Atlanta, Georgia
"With each new prescription we become increasingly poor, and imported drugs should not be unavailable to anyone who wants to purchase them.   We have supported the pharmaceutical companies and their outrageous prices for years and have finally reached the point where enough is enough."
B. A.
Cuyahoga Falls, Ohio
 
vote here
  S 2328:

PHARMACEUTICAL MARKET ACCESS & DRUG SAFETY ACT
 
Would importing prescription drugs put our nation's health at risk?   Or is this the way to get more affordable medicine for the people who need it?   Where do you stand on this proposed legislation?
1. I vote yes!   Bring in the drugs and bring down the costs!

2. I vote no!   Keep me safe and keep the drugs out!

Comments on this issue?

Your name or initials

Your city / town

State / Province

Your country

Your e-mail

How did you
find this web site?

Voter Votes does not share your personal informaton with anyone.

 

Proponents say it's time government caught up with the million or so people who are already saving money by getting their prescriptions filled abroad.   We need regulations to make sure these drugs meet our standards of safety and quality.


Opponents say that quality and safety can never be fully ensured if we import our drugs.   Moreover, by driving prices down, we'll slash the research and development dollars need to come up with breakthrough new technologies.

 
RESULTS OF VOTING
(SO FAR)
Option 1 83.3 %
Option 2 16.7 %
 
 
related legislation
S2328:
PHARMACEUTICAL MARKET ACCESS & DRUG SAFETY ACT

 

From New England to Los Angeles, Miami to Wisconsin, some one million or so consumers, and even some states and local governments are ignoring the law about importing prescription drugs into the U.S.   In response, Congress is looking at the best way to change the law.

The House has already passed its Pharmaceutical Market Access Act (HR2427).   Meanwhile, similar legislation is making its way slowly through the Senate.   The bill getting the most support is the Pharmaceutical Market Access and Drug Safety Act (S2328) which was created and sponsored by a diverse group of Republicans and Democrats led by Sen. Byron Dorgan (D-ND) and Sen. Olympia Snowe (R-ME).   A total of 30 Senators are co-sponsors including Senators McCain, Kennedy, Lott, Daschle, and Kerry.

Basically this legislation legalizes the import of prescription drugs by both individuals and pharmacies for a projected savings to consumers of $38 billion a year.   Drugs from Canada could be imported almost immediately.   A year later, imports from the European Union, Japan, Australia, New Zealand, and Switzerland would also become legal.

Numerous measures are included to ensure the safety and quality of the medicines:

  • Exporters and importers must be registered and approved by the FDA (Food and Drug Administration).
  • The FDA approves the plants where drugs are manufactured.
  • The FDA approves the drugs themselves and can test incoming shipments.
  • All imports require a valid prescription. Controlled substances such as narcotics cannot be imported.
  • All drug containers must be properly labeled.
  • All medicines must have a chain of custody or pedigree that documents every movement beginning at manufacture.
  • Individual supplies may not exceed a 90-day quantity.

Under this plan, both importers (not individuals) and exporters will have to pay fees ranging from $20,000 a year to as much as 1% of the cost of the drugs they're exporting/importing.   These fees are adjustable annually and must cover, but not exceed, the cost of operating this program.

Another section of this bill addresses restraint of trade practices which pharmaceutical companies can and have used to maintain their higher U.S. price point.   Drug manufacturers will not be allowed to make unnecessary or cosmetic changes to a drug simply to put it into an unapproved category.   In addition, drug companies would not be allowed to discriminate against pharmacies that export drugs by charging them higher prices or limiting their supplies.